2.76
Precedente Chiudi:
$2.70
Aprire:
$2.81
Volume 24 ore:
17,194
Relative Volume:
0.03
Capitalizzazione di mercato:
$1.99M
Reddito:
$574.20K
Utile/perdita netta:
$-7.15M
Rapporto P/E:
-0.1738
EPS:
-15.8778
Flusso di cassa netto:
$-7.00M
1 W Prestazione:
-3.01%
1M Prestazione:
+349.95%
6M Prestazione:
+36.55%
1 anno Prestazione:
+25.33%
Aethlon Medical Inc Stock (AEMD) Company Profile
Nome
Aethlon Medical Inc
Settore
Industria
Telefono
619-941-0360
Indirizzo
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
AEMD
Aethlon Medical Inc
|
2.80 | 1.98M | 574.20K | -7.15M | -7.00M | -15.88 |
|
ABT
Abbott Laboratories
|
116.29 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.77 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
93.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
50.78 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-07 | Ripresa | H.C. Wainwright | Neutral |
Aethlon Medical Inc Borsa (AEMD) Ultime notizie
Aethlon (AEMD) Quarterly Results: The EPS Result Is Below Expectation in the Available Record; Price Reaction: The Stock Ends Down 3.81%Earnings Risk Report - Vinanet
Aethlon Medical at emerging growth conference: early cancer signal builds By Investing.com - Investing.com South Africa
Aethlon Medical at emerging growth conference: early cancer signal builds - Investing.com
Aethlon (AEMD) Watch: Trades in a Narrow Directional Range at $2.89; Immediate View: the Price Remains Bounded by the Supplied Support and Resistance on the DayAAII Bullish - Vinanet
Maxim Group Maintains Aethlon Medical(AEMD.US) With Hold Rating - Moomoo
H.C. Wainwright reiterates Aethlon Medical stock rating at Neutral By Investing.com - Investing.com South Africa
Aethlon (AEMD) Quarter in Review: EPS Comes in Below Forecast in the Available Record; Post-Report Move: Shares Finish 4.71% Down in the Latest ReadingAnnual Earnings Summary - Vinanet
Aethlon Medical (AEMD) Falls 3.7% to $2.83 as Support Level LoomsCollar Trade - Vinanet
AEMD Q2 2026 Earnings: Wider-than-Expected Loss of -$4.02 Per Share Highlights Clinical-Stage Challenges - Vinanet
Aethlon Medical, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Aethlon Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Aethlon Medical posts Q1 2026 loss miss as trial advances - Investing.com Nigeria
Aethlon Medical (AEMD) trims quarterly loss and raises $4M in new funding - Stock Titan
Aethlon Medical Q1 Results: EPS misses estimate, losses widen - scanx.trade
Aethlon Medical Advances Hemopurifier Trials and Bolsters Liquidity - TipRanks
AETHLON MEDICAL ($AEMD) Releases Q1 2027 Earnings - Quiver Quantitative
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program - marketscreener.com
Aethlon Medical (AEMD) investors disclose 55,556-share warrant position, 2.3% stake - Stock Titan
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Q1 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Asset turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Inventory turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Total assets of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Diluted shares outstanding of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Net income before discontinued operations of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
AEMD Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Rise 3.75%High Estimate Range - Vinanet
AEMD Q1'26 Earnings: EPS estimate is (3.92) USD - TradingView
Aethlon Medical Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
Aethlon Medical (AEMD.US) will release its earnings report after market close on August 13. - Moomoo
Stock splits calendar for: - Yahoo Finance UK
Aethlon Medical schedules Aug. 13 call on quarter ended June 30 - Stock Titan
Stock Splits Calendar for: - Yahoo! Finance Canada
Market Movers | Winners: AEMD, HYFM, FUSE | Losers: GYGY, CALC, MIRA - Trefis
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
Aethlon Medical To Carry Out 1-for-5 Reverse Stock Split On August 4th, 2026 - Moomoo
AEMD Q2 2026 Earnings: Narrower-Than-Expected Loss Boosts Shares 17%Earnings Acceleration Picks - Vinanet
Aethlon Medical Announces Reverse Stock Split Implementation - TipRanks
Aethlon Medical, Inc. Announces 1-for-5 Reverse Stock Split Effective July 30, 2026 - Minichart
Aethlon Medical (AEMD) Holds Steady Near Support as Trading Volume Remains SubduedBlue Chip Entry Points - Vinanet
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Aethlon Medical, Inc. Revenue Breakdown – NASDAQ:AEMD - TradingView
AEMD Q2 2026 Earnings: Narrower-Than-Expected Loss Per ShareAnnual Earnings Summary - Vinanet
Aethlon Medical (AEMD) Dips 3.4% to $0.63 as Small-Cap Biotech Faces Persistent Selling PressureIntraday Profile - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Aethlon Medical (AEMD) Slips 1.5% as Stock Tests Key Support at $0.63Time Weighted Price - Vinanet
Aethlon Medical at emerging growth conference: trial data and cash boost - Investing.com
AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position - TradingView
Aethlon Medical Reports Encouraging Hemopurifier Trial Results - t.co
Aethlon Medical (AEMD) Gains 2.39% as Stock Approaches $0.70 Resistance LevelSupport Level Bounce - dars.gov.et
Aethlon Medical reports second cohort results from cancer study - Investing.com UK
Aethlon Medical Inc Azioni (AEMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):